Back to search

Immunological analyses of human papillomavirus capsids

Data up to Jan 2025

Published2001
Citations152
References39

Total Citations Per Year

Abstract

References (39)

Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

1995 • 3,371 citations

Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia

1993 • 1,236 citations

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

1992 • 1,086 citations

Human Papillomavirus Infection of the Cervix

2021 • 753 citations

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

1995 • 683 citations

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection

1995 • 597 citations

New mammalian expression vectors

1990 • 525 citations

NEUTRALIZING ANTIVIRAL B CELL RESPONSES

1997 • 467 citations

Molecular Pathogenesis of Cancer of the Cervix and Its Causation by Specific Human Papillomavirus Types

1994 • 381 citations

Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles

1993 • 375 citations

Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic Immunization

1996 • 318 citations

In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype

1996 • 282 citations

Oral Poliovirus Vaccine: History of Its Development and Use and Current Challenge to Eliminate Poliomyelitis from the World

1985 • 274 citations

Human Pathogenic Papillomavirus Types: An Update

1994 • 272 citations

Surface Conformational and Linear Epitopes on HPV-16 and HPV-18 L1 Virus-like Particles as Defined by Monoclonal Antibodies

1996 • 251 citations

The influence of virus structure on antibody responses and virus serotype formation

1996 • 205 citations

Control of Influenza and Poliomyelitis with Killed Virus Vaccines

1977 • 182 citations

Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition

1996 • 179 citations

Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies

1994 • 151 citations

Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera

1994 • 149 citations

Generation and neutralization of pseudovirions of human papillomavirus type 33

1997 • 147 citations

In vitro gene transfer using human papillomavirus-like particles

1998 • 146 citations

Assembly of the Major and the Minor Capsid Protein of Human Papillomavirus Type 33 into Virus-like Particles and Tubular Structures in Insect Cells

1994 • 137 citations

Human Papillomavirus Types 6 and 11 Have Antigenically Distinct Strongly Immunogenic Conformationally Dependent Neutralizing Epitopes

1994 • 131 citations

In Vitro Infection and Type-Restricted Antibody-Mediated Neutralization of Authentic Human Papillomavirus Type 16

1998 • 130 citations

Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope

1997 • 123 citations

Human Papillomavirus Type 11 Recombinant L1 Capsomeres Induce Virus-Neutralizing Antibodies

1998 • 122 citations

Characterization of a Major Neutralizing Epitope on Human Papillomavirus Type 16 L1

1999 • 120 citations

Monoclonal Antibodies to HPV-6 L1 Virus-like Particles Identify Conformational and Linear Neutralizing Epitopes on HPV-11 in Addition to Type-Specific Epitopes on HPV-6

1996 • 120 citations

Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11

1990 • 120 citations

National Institutes of Health Consensus Development Conference Statement on Cervical Cancer

1997 • 102 citations

Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles

1994 • 100 citations

A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera.

1997 • 91 citations

Infectious human papillomavirus type 18 pseudovirions

1998 • 78 citations

Papillomavirus-like particle vaccines for cervical cancer

1999 • 77 citations

Isolation and Propagation of Human Papillomavirus Type 16 in Human Xenografts Implanted in the Severe Combined Immunodeficiency Mouse

1998 • 55 citations

A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitope

1997 • 46 citations

Expression in Escherichia coli of Seven DNA Fragments Comprising the Complete L1 and L2 Open Reading Frames of Human Papillomavirus Type 6b and Localization of the 'Common Antigen' Region

1989 • 40 citations

Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles

1990 • 30 citations

Cited By (0)

No citing papers found in database

Immunological analyses of human papillomavirus capsids (2001) – Vaccine | Metascience Observatory Explorer